share_log

Merck & Co | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 14 17:38
Summary by Moomoo AI
Merck & Co. Inc. officer Robert M. Davis is set to sell 85,021 shares of the company's common stock on February 14, 2024, according to a recent filing. The shares, valued at an aggregate market value of $10,661,573.89, were acquired on the same date through the exercise of options under a registered plan. The transaction involves the payment of cash to the issuer for the securities. This sale follows a previous transaction in the past three months where Davis sold 150,000 shares for a total gross proceed of $18,872,130.
Merck & Co. Inc. officer Robert M. Davis is set to sell 85,021 shares of the company's common stock on February 14, 2024, according to a recent filing. The shares, valued at an aggregate market value of $10,661,573.89, were acquired on the same date through the exercise of options under a registered plan. The transaction involves the payment of cash to the issuer for the securities. This sale follows a previous transaction in the past three months where Davis sold 150,000 shares for a total gross proceed of $18,872,130.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more